Stoke Therapeutics (STOK) Non-Current Deffered Revenue (2022 - 2026)
Stoke Therapeutics (STOK) reported Non-Current Deffered Revenue of $5.65 million for Q2 2026, down 41.3% from $9.63 million a year earlier and down 14.4% from the prior quarter.
Powered by 
Analysis
Stoke Therapeutics (STOK) Non-Current Deffered Revenue (2022 - 2026) Analysis & Trends
At the end of FY2025, Stoke Therapeutics posted Non-Current Deffered Revenue of $6.96 million.
- Non-Current Deffered Revenue has a three-year compound annual growth rate of -42.6% (FY2022 to FY2025).
- By year, Non-Current Deffered Revenue came in at $33.07 million in FY2023 (-10.3%) and $36.86 million in FY2022.
- The Q2 2026 figure ranks as the lowest quarterly Non-Current Deffered Revenue in data going back to Q1 2022.
- Year over year, Non-Current Deffered Revenue gained in 1 of the last six quarters, with an average decline of 42.6%.
- The high point for year-over-year Non-Current Deffered Revenue in five years was Q3 2025 (growth of 3.2%); the low point was Q3 2024 (a decline of 79.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $6.6 million (Q1 2026), $6.96 million (Q4 2025) and $8.56 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Stoke Therapeutics | 1.62 Bn | 453.12 Mn | - | 5.65 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.65 Mn |
| Mar 31, 2026 | 6.60 Mn |
| Dec 31, 2025 | 6.96 Mn |
| Sep 30, 2025 | 8.56 Mn |
| Jun 30, 2025 | 9.63 Mn |
| Mar 31, 2025 | 10.26 Mn |
| Sep 30, 2024 | 8.29 Mn |
| Jun 30, 2024 | 16.95 Mn |
| Mar 31, 2024 | 25.04 Mn |
| Dec 31, 2023 | 33.07 Mn |
| Sep 30, 2023 | 40.73 Mn |
| Jun 30, 2023 | 43.26 Mn |
| Mar 31, 2023 | 34.14 Mn |
| Dec 31, 2022 | 36.86 Mn |
| Sep 30, 2022 | 41.08 Mn |
| Jun 30, 2022 | 45.21 Mn |
| Mar 31, 2022 | 49.55 Mn |
API Access
Stoke Therapeutics Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=STOK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "STOK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=STOK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();